TRUIST FINANCIAL CORP - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2023$161,550
+6.5%
45,0000.0%0.00%
Q1 2023$151,650
+117.4%
45,0000.0%0.00%
Q4 2022$69,750
+14.3%
45,0000.0%0.00%
Q3 2022$61,000
-35.8%
45,0000.0%0.00%
Q2 2022$95,000
-34.0%
45,0000.0%0.00%
Q1 2022$144,000
-23.8%
45,0000.0%0.00%
Q4 2021$189,000
-48.2%
45,0000.0%0.00%
-100.0%
Q3 2021$365,000
+7.4%
45,0000.0%0.00%0.0%
Q2 2021$340,000
-13.0%
45,0000.0%0.00%0.0%
Q1 2021$391,000
+8.9%
45,0000.0%0.00%0.0%
Q4 2020$359,00045,0000.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders